Literature DB >> 16100964

Frequency of obsessive and compulsive symptoms in patients with blepharospasm and hemifacial spasm.

Renato P Munhoz1, Helio A G Teive, Marcus V Della Coletta, Francisco M B Germiniani, Fábio M Iwamoto, Carlos H F Camargo, Lineu César Werneck.   

Abstract

BACKGROUND: Blepharospasm (BS) is a form of central focal dystonia recently associated with psychiatric disorders, particularly obsessive and compulsive symptoms. Hemifacial spasm (HFS) represents a focal myoclonus with peripheral origin in the facial nerve.
OBJECTIVE: To determine the frequency of obsessive and compulsive symptoms in patients with BS in comparison with patients with HFS.
METHODS: 30 patients from each group (BS and HFS) followed by the botulinum toxin clinic at the HC-UFPR were evaluated using a structured interview based on the DSM-IV criteria and the Yale-Brown scale. Results were compared by the mean two-tailed t test.
RESULTS: We found obsessive or compulsive symptoms in 20 (66.6%) patients with BE and 21 (70%) with HFS. Yale-Brown scale scores for each group were higher among BS patients; however, diferences were not statisticaly significant.
CONCLUSION: Our study did not show a significant diference in the comparison of the prevalence of obsessive and compulsive symptoms among patients with BS and HFS.

Entities:  

Mesh:

Year:  2005        PMID: 16100964     DOI: 10.1590/s0004-282x2005000200004

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  5 in total

Review 1.  Blepharospasm 40 years later.

Authors:  Giovanni Defazio; Mark Hallett; Hyder A Jinnah; Antonella Conte; Alfredo Berardelli
Journal:  Mov Disord       Date:  2017-02-10       Impact factor: 10.338

2.  Patients with Cervical Dystonia Demonstrated Decreased Cognitive Abilities and Visual Planning Compared to Controls.

Authors:  Marina S C Bastos; Renato Nickel; Carlos H F Camargo; Hélio A G Teive
Journal:  Mov Disord Clin Pract       Date:  2021-06-19

3.  Psychiatric disorders in primary focal dystonia and in Parkinson's disease.

Authors:  Fernando Mv Dias; Arthur Kummer; Flávia Cp Doyle; Estefânia Harsányi; Francisco Cardoso; Leonardo F Fontenelle; Antônio Lúcio Teixeira
Journal:  Neuropsychiatr Dis Treat       Date:  2011-03-14       Impact factor: 2.570

4.  Sexual Well-Being in Patients with Blepharospasm, Spasmodic Torticollis, and Hemifacial Spasm: A Pilot Study.

Authors:  Paola Perozzo; Adriana Salatino; Paolo Cerrato; Raffaella Ricci
Journal:  Front Psychol       Date:  2016-10-05

5.  Botulinum toxin relieves anxiety and depression in patients with hemifacial spasm and blepharospasm.

Authors:  Hongjuan Dong; Shanghua Fan; Ying Luo; Bin Peng
Journal:  Neuropsychiatr Dis Treat       Date:  2018-12-19       Impact factor: 2.570

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.